This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on ISI (1)  • Contact me when this article is cited  Related Content  • Related letter  • Related article  • Similar articles in this journal  Topic Collections  • Treatment Adherence  • Psoriasis  • Phototherapy  • Drug Therapy  • Adherence  • Alert me on articles by topic

A Fundamental Principle of Dermatology

Saba M. Ali, BS; Robert T. Brodell, MD; Rajesh Balkrishnan, PhD; Steven R. Feldman, MD, PhD

Arch Dermatol. 2007;143(7):912-915.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The long-term longitudinal follow-up study of a cohort of psoralen UV-A (PUVA)-treated patients by Jones-Caballero et al¹ published in this issue of the Archives provides insight into the complexities of treating psoriasis and the impact of the disease on patients' lives. Psoriasis is a chronic, frustrating condition, and much of the frustration comes from the need to continually use treatments over time. None of the treatments are entirely satisfactory, and as time goes by many patients grow progressively less tolerant of treatment. In the 1970s, PUVA treatment might have seemed to be a relief from the messy and time-consuming Goeckerman treatment. Jones-Caballero et al¹ found that most patients treated with PUVA eventually gravitated to other treatment options. Those leaving PUVA for biological treatments were younger, had more formal education, and were more likely to . . . [Full Text of this Article]

THE RESISTANCE OF SCALP PSORIASIS TO TOPICAL TREATMENT


CORAL REEF PSORIASIS

USE NEW MEDICATIONS AS SOON AS THEY ARE INTRODUCED, BEFORE THEY STOP WORKING

SEVERE ATOPIC DERMATITIS CLEARS RAPIDLY IN HOSPITALIZED PATIENTS

PSYCHONEUROIMMUNOLOGY

PHARMACOGENOMICS

GREATER PATIENT SATISFACTION IMPROVES TREATMENT OUTCOMES

ZINC PYRITHIONE SPRAY

IS POOR ADHERENCE EVER A GOOD THING?

TACHYPHYLAXIS

SUMMARY

AUTHOR INFORMATION

RELATED LETTER

Success of Goeckerman Treatment in 2 Patients With Psoriasis Not Responding to Biological Drugs
Temitope F. Soares and Mark D. P. Davis
Arch Dermatol. 2007;143(7):950-951.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Use of Biological Agents in Patients With Moderate to Severe Psoriasis: A Cohort-Based Perspective
María Jones-Caballero, Jane Unaeze, Pablo F. Peñas, and Robert S. Stern
Arch Dermatol. 2007;143(7):846-850.
ABSTRACT | FULL TEXT